BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/4/2024 12:05:26 PM | Browse: 123 | Download: 54
Publication Name World Journal of Diabetes
Manuscript ID 89369
Country/Territory United States
Received
2023-11-03 10:12
Peer-Review Started
2023-11-03 10:14
To Make the First Decision
Return for Revision
2023-12-06 08:04
Revised
2023-12-17 17:46
Second Decision
2024-01-08 00:44
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2024-01-16 05:33
Articles in Press
2024-01-16 05:33
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-01-30 02:58
Publish the Manuscript Online
2024-02-04 10:57
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Editorial
Article Title Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon
Manuscript Source Invited Manuscript
All Author List Mahmoud Nassar, Ajay Chaudhuri, Husam Ghanim and Paresh Dandona
Funding Agency and Grant Number
Corresponding Author Mahmoud Nassar, MD, MSc, PhD, Doctor, Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, Jacobs School of Medicine and Biomedical Sciences, University of Buffalo, 705 Maple Road, Buffalo, NY 14221, United States. dr.nassar@aucegypt.edu
Key Words Type 1 diabetes; Semaglutide; Glucagon-like peptide-1 receptor agonists; Insulin therapy; Autoimmune response; Blood glucose monitoring; Β-cell preservation; Early screening; Teplizumab; Randomized controlled trials
Core Tip New research suggests a novel approach to treating type 1 diabetes (T1D) by using glucagon-like peptide-1 receptor agonists, specifically semaglutide, to significantly improve blood glucose control and potentially slow the progression of the disease in newly diagnosed patients. This strategy, which leads to less insulin dependence and better metabolic markers, could change the way T1D is managed in a big way. At the same time, the study supports early T1D risk screening, especially in groups with high risk, so that early interventions can be made, evaluating the benefits against the possible emotional and financial effects. This dual approach shows that there are bright futures for improving the lives of patients with T1D.
Publish Date 2024-02-04 10:57
Citation Nassar M, Chaudhuri A, Ghanim H, Dandona P. Glucagon-like peptide-1 receptor agonists as a possible intervention to delay the onset of type 1 diabetes: A new horizon. World J Diabetes 2024; 15(2): 133-136
URL https://www.wjgnet.com/1948-9358/full/v15/i2/133.htm
DOI https://dx.doi.org/10.4239/wjd.v15.i2.133
Full Article (PDF) WJD-15-133-with-cover.pdf
Full Article (Word) WJD-15-133.docx
Manuscript File 89369_Auto_Edited-YJP.docx
Answering Reviewers 89369-Answering reviewers.pdf
Audio Core Tip 89369-Audio core tip.wav
Conflict-of-Interest Disclosure Form 89369-Conflict-of-interest statement.pdf
Copyright License Agreement 89369-Copyright license agreement.pdf
Peer-review Report 89369-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 89369-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 89369-Bing-Li L-2.png
Scientific Editor Work List 89369-Scientific editor work list.pdf